Kuse ER - Search Results

1

HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.

Rosenau J, Kreutz T, Kujawa M, Bahr MJ, Rifai K, Hooman N, Finger A, Michel G, Nashan B, Kuse ER, Klempnauer J, Tillmann HL, Manns MP. Rosenau J, et al. Among authors: kuse er. J Hepatol. 2007 Apr;46(4):635-44. doi: 10.1016/j.jhep.2006.11.022. Epub 2007 Jan 25. J Hepatol. 2007. PMID: 17316869

2

Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.

Lück R, Böger J, Kuse E, Klempnauer J, Nashan B. Lück R, et al. Liver Transpl. 2004 May;10(5):686-91. doi: 10.1002/lt.20117. Liver Transpl. 2004. PMID: 15108262 Free article.

3

Hepatic reticuloendothelial function during parenteral nutrition including an MCT/LCT or LCT emulsion after liver transplantation - a double-blind study.

Kuse ER, Kotzerke J, Müller S, Nashan B, Lück R, Jaeger K. Kuse ER, et al. Transpl Int. 2002 Jun;15(6):272-7. doi: 10.1007/s00147-002-0393-1. Epub 2002 Apr 30. Transpl Int. 2002. PMID: 12072897 Clinical Trial.

4

Recurrent cardiocirculatory arrest after kidney transplantation related to intravenous methylprednisolone bolus therapy.

Schult M, Löhmann D, Knitsch W, Kuse ER, Nashan B. Schult M, et al. Among authors: kuse er. Transplantation. 1999 Jun 15;67(11):1497-8. doi: 10.1097/00007890-199906150-00022. Transplantation. 1999. PMID: 10385096

5

Long-term safety, tolerability and efficacy of daclizumab (Zenapax) in a two-dose regimen in liver transplant recipients.

Niemeyer G, Koch M, Light S, Kuse ER, Nashan B. Niemeyer G, et al. Among authors: kuse er. Am J Transplant. 2002 May;2(5):454-60. doi: 10.1034/j.1600-6143.2002.20510.x. Am J Transplant. 2002. PMID: 12123212 Free article.

6

Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis.

Kielstein JT, Czock D, Schöpke T, Hafer C, Bode-Böger SM, Kuse E, Keller F, Fliser D. Kielstein JT, et al. Crit Care Med. 2006 Jan;34(1):51-6. doi: 10.1097/01.ccm.0000190243.88133.3f. Crit Care Med. 2006. PMID: 16374156 Clinical Trial.

7

Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.

Czock D, Hüsig-Linde C, Langhoff A, Schöpke T, Hafer C, de Groot K, Swoboda S, Kuse E, Haller H, Fliser D, Keller F, Kielstein JT. Czock D, et al. Clin J Am Soc Nephrol. 2006 Nov;1(6):1263-8. doi: 10.2215/CJN.01840506. Epub 2006 Sep 27. Clin J Am Soc Nephrol. 2006. PMID: 17699357

8

[Transplantation: potential indication for antioxidants?].

Kuse ER. Kuse ER. Dtsch Med Wochenschr. 2009 Dec;134 Suppl 11:S425-6. doi: 10.1055/s-0029-1243043. Epub 2009 Dec 8. Dtsch Med Wochenschr. 2009. PMID: 19998237 Review. German. No abstract available.

9

Energy expenditure and energy intake - Guidelines on Parenteral Nutrition, Chapter 3.

Kreymann G, Adolph M, Mueller MJ; Working group for developing the guidelines for parenteral nutrition of The German Association for Nutritional Medicine. Kreymann G, et al. Ger Med Sci. 2009 Nov 18;7:Doc25. doi: 10.3205/000084. Ger Med Sci. 2009. PMID: 20049085 Free PMC article. Review.

10

Hepatology - Guidelines on Parenteral Nutrition, Chapter 16.

Plauth M, Schuetz T; Working group for developing the guidelines for parenteral nutrition of The German Association for Nutritional Medicine. Plauth M, et al. Ger Med Sci. 2009 Nov 18;7:Doc12. doi: 10.3205/000071. Ger Med Sci. 2009. PMID: 20049084 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters